Reflections On Ethical Adoption Of Decentralized Clinical ResearcH Capabilities
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 25-006942
- Jacksonville, Florida: 25-006942
About this study
This is an exploratory qualitative study. We intend to (1) Explore perceptions of the quality, reliability, and appropriateness of remote study processes and interventions of research investigators and study participants who engage with Clinical Trials Beyond Walls services and (2) Evaluate investigators’ view of facilitators and barriers to scalability of decentralized capabilities their own studies and strategies to promote best practices for participation in decentralized clinical trials among historically underrepresented communities in clinical research.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Investigators: Principal investigators and study staff, hereinafter “investigators”, that engage with the CTBW team and have completed or ongoing data collection and trial participant recruitment using decentralized methods; ability to converse in English; legal adult 18 years of age or older with the capacity to consent to participating in this study.
Trial Participants: Individuals who are or were enrolled in a decentralized trial associated with CTBW; ability to converse in English; legal adult 18 years of age or older with the capacity to consent to participating in this study.
Exclusion Criteria:
Investigators: Not an investigator that engage with CTBW and has completed or ongoing data collection using decentralized methods.
Trial Participants: Not a participant currently or priorly enrolled in a decentralized trial associated with CTBW.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 2/5/2026. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Michelle McGowan, Ph.D. |
Open for enrollment |
|
Jacksonville, Fla.
Mayo Clinic principal investigator Michelle McGowan, Ph.D. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available